As of 9:30 AM on the 14th, United Pharm is trading at 26,850 KRW, up 1.32% from the previous day. This represents a 23.73% increase compared to June 19. United Pharm is known as a specialized pharmaceutical manufacturing and sales company.
Over the past 5 days, individual investors have net purchased 210,969 shares, while foreigners and institutions have net sold 155,450 shares and 63,384 shares, respectively.
On July 10, United Pharm became a market topic with the news of the US patent for the next-generation liver treatment 'Oranopin,' causing the stock to rise.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![User Who Sold Erroneously Deposited Bitcoins to Repay Debt and Fund Entertainment... What Did the Supreme Court Decide in 2021? [Legal Issue Check]](https://cwcontent.asiae.co.kr/asiaresize/183/2026020910431234020_1770601391.png)
